Bone and Joint Infection

Pipeline Programs↗

Active Trials↗

Companies Involved↗

Bone and Joint Infection is an early-stage landscape with 0 programs across 0 companies.

Intelligence

Pipeline Metrics

Competitive Density

16/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

67/100

Attrition Rate

20/100

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

clinical trials

Completed4 · 40%

Recruiting2 · 20%

Active, not recruiting1 · 10%

Not yet recruiting1 · 10%

Withdrawn1 · 10%

Terminated1 · 10%

Clinical Trials

Trial Activity

10 trials

BonE and Joint Infections - Simplifying Treatment in Children Trial

Recruiting·MMurdoch Childrens Research Institute·Phase 4·NCT04538053·285 enrolled

Initial Oral Antibiotics for Bone and Joint Infections in Children

Recruiting·—·N/A·NCT06827496·100 enrolled

Controlled Trial of Omadacycline Randomized Treatment Given for Bone and Joint Infection

Active, not recruiting·LLundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center·Phase 2·NCT05753215·180 enrolled

Delafloxacin Plasma and Tissue Concentration in Patients With Skin, Soft Tissue, and Bone and Joint Infections.

Not yet recruiting·IIRCCS San Raffaele·N/A·NCT07426471·20 enrolled

Clindamycin-rifampin Drug Interaction in the Treatment of Bone and Joint Infections

Completed·GGroupe Hospitalier Diaconesses Croix Saint-Simon·N/A·NCT02629770·49 enrolled

Tolerability, Safety, and Efficacy of Tedizolid as Oral Treatment for Bone and Joint Infections (OTTER)

Completed·LLundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center·Phase 2·NCT03009045·44 enrolled

Oral Versus Intravenous Antibiotics for Bone and Joint Infections (OVIVA B&J)

Completed·OOxford University Hospitals NHS Trust·Phase 4·NCT00974493·1,054 enrolled

Oral-only Antibiotics for Bone and Joint Infections in Children

Completed·—·Phase 4·NCT04563325·180 enrolled

Stool Biobanking and Impact of Antimicrobials on the Gut Microbiota in Patients With Bone and Joint Infection

Terminated·HHospices Civils de Lyon·N/A·NCT03633188·12 enrolled

Ceftaroline in the Treatment of Bone and Joint Infections

Withdrawn·OOrlando Health, Inc.·Phase 4·NCT02005068

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)